Haleon plc is about to pay a
£0.046 Dividend. The company's
stock performance shows rising relative price strength. Haleon recently executed a
$0.2 billion deal to fully
control its
China JV. Amidst the stock market sell-off, Haleon is being regarded as a
defensive play. After successfully executing a
share buyback as part of its capital management strategy, Haleon has updated its
share count and
voting rights.
The company's
revenue growth for 2025 is projected to be skewed towards the
second half.
Pfizer recently sold its final stake in Haleon, which resulted in Haleon's stock coming under scrutiny. Consequently, Haleon
plc shares are likely to face a
downturn. However,
Haleon's executives have already taken prescriptive measures by acquiring shares under a
reward plan.
HSBC recently cut its Haleon stock rating while maintaining a GBP4.20 target.
Haleon continues driving its market position and shareholder value by executing share buybacks, even as it faces growth concerns and competition in the Oral Care segment.
Haleon Stocks News Analytics from Mon, 05 Aug 2024 07:00:00 GMT to Sat, 19 Apr 2025 07:21:35 GMT -
Rating 4
- Innovation 3
- Information -2
- Rumor 6
